Susan Hasty, Publisher
Table of Contents . . . August 28th, 1995Non-Subscriber - Summaries Only
Antisense Technology - Self-Stabilized Oligodeoxynucleotide May Be Useful as Therapeutic Agent
Electronic Publishing - Henderson Newsletters Offered Electronically or by E-mail
Industry News/Alzheimer's - Gene Discovered on Chromosome 1
Industry News/Diagnostics - Enzyme Technology Accelerates DNA Sequencing Efforts Worldwide
Industry News/Funding - Second SBIR Received for In Vivo Gene Therapy Program
Industry News/Funding - Establishment of Three National Gene Vector Laboratories Announced
Industry News/Joint Venture - Collaboration To Develop Needle-Free Injector for Use in Gene Therapy
Industry News/Patents and Technology - Replication and Genetic Transformation of Human Stem Cells Patents Awarded
Industry News/Patents and Technology - Issuance for VX-366 To Treat Genetic Hemoglobin Disorders Announced
Industry News/Patents and Technology - Allowance Received for Proprietary Zyn-Linker Drug Delivery
Industry News/Testing - Agreement Signed To Establish Cancer Risk Assessment Program
Industry News/Therapy - Company Discovers Signal Transduction Inhibitors for GRB2
Therapy - Mechanism Could Lead to New Drugs
Drug Development - Gene Therapy - "Adjuvant Therapy Strategies for the Future."
Drug Development - Vaccines - "Different Strategies Towards the Design of a Synthetic Subunit Malaria Vaccine."
Pathogenesis - "Genetic Determinants of Host Susceptibility."
Therapy - Gene Manipulation - "Gene Therapy for HIV Infection."
Therapy - Genetic Manipulation - "Control of Oncogenes by Antisense Oligo-Nucleotides: Dream or Reality?."
Therapy - Genetic Manipulation - "Gene Therapy of Infectious Diseases and Cancer."
Autoimmune Disease - "Biological Therapies: A Novel Approach to the Treatment of Autoimmune Disease."
Chronic Granulomatous Disease - "Functional Reconstitution of the NADPH-Oxidase by Adeno-Associated Virus Gene Transfer."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.